24 HR desvenlafaxine succinate 25 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies ( 14 )] . Desvenlafaxine extended-release tablets are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).

actavis pharma, inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] off label use` `[5] headache` `[6] diarrhoea` `[7] dyspnoea` `[8] pain` `[9] death` `[10] arthralgia`

4 years ago

SQUARE PINK A112

16 HOW SUPPLIED/STORAGE AND HANDLING

DESVENLAFAXINE extended-release tablets are available as follows: 25 mg, light pink, square, pyramid tablets imprinted with “A112” in black ink on one side NDC 0591-4060-30, bottle of 30 tablets in unit-of-use package 50 mg, light pink, square, pyramid tablets imprinted with “WPI” and “3659” in black ink on one side NDC 0591-3659-30, bottle of 30 tablets in unit-of-use package 100 mg, reddish-orange, square, pyramid tablets imprinted with “WPI” and “3660” in black ink on one side NDC 0591-3660-30, bottle of 30 tablets in unit-of-use package Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Each tablet contains 38 mg, 76 mg or 152 mg of

DESVENLAFAXINE succinate equivalent to 25 mg, 50 mg or 100 mg of

DESVENLAFAXINE, respectively.

More pills like SQUARE A112

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

24 HR desvenlafaxine succinate 25 MG Extended Release Oral Tablet

FDA Reported Adverse Reactions [1] fatigue [2] nausea [3] drug ineffective [4] off label use [5] headache [6] diarrhoea [7] dyspnoea [8] pain [9] death [10] arthralgia

SQUARE PINK A112

More pills like SQUARE A112

FDA Reported Adverse Reactions
`[1] fatigue` `[2] nausea` `[3] drug ineffective` `[4] off label use` `[5] headache` `[6] diarrhoea` `[7] dyspnoea` `[8] pain` `[9] death` `[10] arthralgia`